Hyperthermic Intraperitoneal Chemotherapy plus Intravenous Chemotherapy of Paclitaxel with or without Sintilimab in Gastric Cancer: A Comparative Study

Table 5

Comparison of the adverse effects.

	All grade AEs		Grade ≥3 AEs
	No.	%	No.	%
Control group (n = 60)	53	83.33	33	55.00
Study group (n = 60)	51	85.00	26	43.33
χ^2	0.289		1.634
value	0.296		0.101

AEs, adverse events.